TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biomedola AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
105
|
87
|
76 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
74
|
67
|
53 |
| EBITDA |
70
|
67
|
53 |
| Total assets |
455
|
406
|
399 |
| Current assets |
279
|
230
|
208 |
| Current liabilities |
19
|
13
|
13 |
| Equity capital |
407
|
366
|
358 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
89.5%
|
90.1%
|
89.7% |
| Turnover per employee |
105
|
87
|
76 |
| Profit as a percentage of turnover |
70.5%
|
77.0%
|
69.7% |
| Return on assets (ROA) |
16.3%
|
16.5%
|
13.3% |
| Current ratio |
1468.4%
|
1769.2%
|
1600% |
| Return on equity (ROE) |
18.2%
|
18.3%
|
14.8% |
| Change turnover |
18
|
17
|
-33 |
| Change turnover % |
21%
|
24%
|
-30% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.